Clinical Trial Update: Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing adrenal suppression and systemic absorption after multiple dosing of DFD-06 in psoriasis; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• DFD-06

Snippet

Sponsor: Primus Pharmaceuticals | Conditions: Psoriasis | Phase 2 | Status: TERMINATED | Results posted: 2022-06-01